Consistent with these findings, the expression levels of NLRP3, the cleaved form of Caspase-1, IL-18, and IL-1β were markedly reduced in the GSDMD−/− mice with NASH. The gene discussed is NLRP3; the disease is metabolic dysfunction-associated steatohepatitis.